BIRMINGHAM, Alabama., July 20, 2022 /PRNewswire/ — Encompass Health Corporation (NYSE: EHC) today announced that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on October 17, 2022to holders of a file on October 3, 2022.
The revised quarterly dividend follows the recently completed spin-off of Enhabit Home Health & Hospice and reflects the company’s continued commitment to a strong de novo hospital strategy. Encompass Health will open 9 de novo rehabilitation hospitals this year and intends to open a similar number in 2023.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in United States. With a national footprint that includes 150 hospitals in 35 states and Porto Rico, the company provides high-quality, compassionate rehabilitation care to patients recovering from serious injury or illness, using cutting-edge technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune’s 100 Best Companies to Work For and one of Modern Healthcare’s Best Places to Work in Healthcare. For more information, visit surroundhealth.com, or follow us on our newsroom, TwitterInstagram and Facebook.
Statements in this press release that are not historical facts, such as the timing and amounts of dividends and the opening of new hospitals, are forward-looking statements. within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements regarding the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no obligation to publicly update or revise such forward-looking information, whether as a result of new information, future events or otherwise. These forward-looking statements are necessarily estimates based on current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements due to a variety of factors. While it is impossible to identify all of these factors, factors that could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, the regulatory review and approval process; the possibility of hospital construction experiencing unexpected delays or prohibitive cost increases; a hospital’s ability to receive and maintain appropriate local, state and federal licensing; the ability to attract and retain nurses, therapists and other healthcare professionals in a highly competitive environment with often severe staffing shortages; the continued spread of COVID-19 or another infectious disease, including the speed, depth, geographic range and duration of spread, which could reduce our patient volumes and revenues and lead to staffing shortages and procurement and associated cost increases; measures to be taken by Embrace health in response to the pandemic; legal, regulatory and administrative developments occurring at the federal, state and local levels; Embrace health infectious disease prevention and control efforts; Encompass Health’s ability to comply with extensive, complex and constantly changing healthcare industry regulations; any adverse results of various lawsuits, claims, and judicial or regulatory proceedings involving Encompass Health, including any matters related to as yet undiscovered issues, if any, in acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health’s information systems, including unauthorized access to or theft of patients, business associates, or other information sensitive; changes, delays (including in the resolution of Medicare payment reviews or appeals) or suspension of reimbursement for Encompass Health services by government or private payers; and other factors that may be identified from time to time in Encompass Health’s filings with the SEC and other public announcements, including Encompass Health Form 10-K for the fiscal year ended December 31, 2021 and Form 10-Q for the quarter ended March 31, 2022.
Casey Winger | 205 447-6410
Contact with Investor Relations:
Mark Miller | 205 970-5860
SOURCEEncompass Health Corp.